West Branch Capital’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.5K | Sell |
80
-25
| -24% | -$5.47K | 0.01% | 220 |
|
|
2025
Q1 | $23.5K | Hold |
105
| – | – | 0.01% | 209 |
|
|
2024
Q4 | $34.4K | Hold |
105
| – | – | 0.01% | 179 |
|
|
2024
Q3 | $31.5K | Hold |
105
| – | – | 0.01% | 189 |
|
|
2024
Q2 | $34.6K | Hold |
105
| – | – | 0.01% | 181 |
|
|
2024
Q1 | $41.6K | Hold |
105
| – | – | 0.02% | 170 |
|
|
2023
Q4 | $37K | Hold |
105
| – | – | 0.02% | 180 |
|
|
2023
Q3 | $39.4K | Hold |
105
| – | – | 0.02% | 173 |
|
|
2023
Q2 | $40.2K | Hold |
105
| – | – | 0.02% | 176 |
|
|
2023
Q1 | $36.4K | Hold |
105
| – | – | 0.02% | 190 |
|
|
2022
Q4 | $24.7K | Hold |
105
| – | – | 0.02% | 209 |
|
|
2022
Q3 | $26K | Hold |
105
| – | – | 0.02% | 208 |
|
|
2022
Q2 | $32K | Hold |
105
| – | – | 0.02% | 200 |
|
|
2022
Q1 | $43K | Hold |
105
| – | – | 0.02% | 197 |
|
|
2021
Q4 | $49K | Hold |
105
| – | – | 0.02% | 199 |
|
|
2021
Q3 | $45K | Hold |
105
| – | – | 0.02% | 193 |
|
|
2021
Q2 | $38K | Buy |
+105
| New | +$38K | 0.02% | 212 |
|